Takemi Kimura

1.3k total citations
33 papers, 896 citations indexed

About

Takemi Kimura is a scholar working on Physiology, Neurology and Psychiatry and Mental health. According to data from OpenAlex, Takemi Kimura has authored 33 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Physiology, 12 papers in Neurology and 8 papers in Psychiatry and Mental health. Recurrent topics in Takemi Kimura's work include Alzheimer's disease research and treatments (23 papers), Neurological Disease Mechanisms and Treatments (6 papers) and Dementia and Cognitive Impairment Research (6 papers). Takemi Kimura is often cited by papers focused on Alzheimer's disease research and treatments (23 papers), Neurological Disease Mechanisms and Treatments (6 papers) and Dementia and Cognitive Impairment Research (6 papers). Takemi Kimura collaborates with scholars based in Japan, India and Ireland. Takemi Kimura's co-authors include Taihei Miyakawa, Junichi Takamatsu, Shoichi Katsuragi, Koko Ishizuka, Ruriko Igata‐Yi, Seikoh Horiuchi, Hideyuki Yamamoto, Tsunehiko Ono, Akira Kondo and Eishichi Miyamoto and has published in prestigious journals such as Biological Psychiatry, Annals of the New York Academy of Sciences and Journal of Neurochemistry.

In The Last Decade

Takemi Kimura

33 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takemi Kimura Japan 18 538 300 226 143 127 33 896
Junichi Takamatsu Japan 15 513 1.0× 279 0.9× 217 1.0× 129 0.9× 151 1.2× 25 844
J.E. McKenzie United Kingdom 6 456 0.8× 381 1.3× 353 1.6× 132 0.9× 150 1.2× 7 940
Amita Quadros United States 14 673 1.3× 403 1.3× 334 1.5× 150 1.0× 86 0.7× 18 1.1k
Jianting Miao China 18 638 1.2× 200 0.7× 307 1.4× 187 1.3× 126 1.0× 30 1.0k
Sun-Ho Han South Korea 14 630 1.2× 259 0.9× 400 1.8× 85 0.6× 50 0.4× 17 1.0k
Ian D. Daugs United States 13 558 1.0× 202 0.7× 198 0.9× 95 0.7× 113 0.9× 13 770
Maj‐Linda B. Selenica United States 13 379 0.7× 246 0.8× 262 1.2× 91 0.6× 111 0.9× 19 717
Melissa Freeman United States 13 910 1.7× 515 1.7× 421 1.9× 178 1.2× 199 1.6× 21 1.5k
Doris Dea Canada 21 745 1.4× 207 0.7× 514 2.3× 228 1.6× 91 0.7× 35 1.3k

Countries citing papers authored by Takemi Kimura

Since Specialization
Citations

This map shows the geographic impact of Takemi Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takemi Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takemi Kimura more than expected).

Fields of papers citing papers by Takemi Kimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takemi Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takemi Kimura. The network helps show where Takemi Kimura may publish in the future.

Co-authorship network of co-authors of Takemi Kimura

This figure shows the co-authorship network connecting the top 25 collaborators of Takemi Kimura. A scholar is included among the top collaborators of Takemi Kimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takemi Kimura. Takemi Kimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Kimura, Takemi, et al.. (2010). Pilot study of pharmacological treatment for frontotemporal dementia: Effect of Yokukansan on behavioral symptoms. Psychiatry and Clinical Neurosciences. 64(2). 207–210. 18 indexed citations
4.
Jono, Tadashi, Takemi Kimura, Junichi Takamatsu, et al.. (2002). Accumulation of imidazolone, pentosidine and Nɛ‐(carboxymethyl)lysine in hippocampal CA4 pyramidal neurons of aged human brain. Pathology International. 52(9). 563–571. 41 indexed citations
5.
Kimura, Takemi, Noboru Fujise, Tsunehiko Ono, et al.. (2002). Identification of an aging‐related spherical inclusion in the human brain. Pathology International. 52(10). 636–642. 4 indexed citations
6.
Kimura, Takemi, et al.. (2000). Phosphorylation of MARCKS in Alzheimer disease brains. Neuroreport. 11(4). 869–873. 25 indexed citations
7.
Kimura, Takemi, Masahiro Shono, Koko Ishizuka, et al.. (2000). Apolipoprotein E ϵ4 and tardive dyskinesia in a Japanese population. Journal of Psychiatric Research. 34(4-5). 329–332. 13 indexed citations
8.
Kimura, Takemi, et al.. (2000). Apolipoprotein E ε3 Allele Is Not a Risk Factor of Schizophrenia: A Study of 314 Japanese Patients. Neuropsychobiology. 42(2). 66–68. 6 indexed citations
9.
Takeuchi, Yusuke, Hideyuki Yamamoto, Kunio Matsumoto, et al.. (1999). Nuclear Localization of the δ Subunit of Ca2+/Calmodulin‐Dependent Protein Kinase II in Rat Cerebellar Granule Cells. Journal of Neurochemistry. 72(2). 815–825. 33 indexed citations
10.
Takamatsu, Junichi, Takemi Kimura, Akira Kondo, & Takeshi Iwatsubo. (1997). Subpial Amyloid Plaques in the Cerebellum in a Case of Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders. 8(3). 157–162. 4 indexed citations
11.
Ishizuka, Koko, Ruriko Igata‐Yi, Takemi Kimura, et al.. (1997). Expression and distribution of CC chemokine macrophage inflammatory protein-1α/LD78 in the human brain. Neuroreport. 8(5). 1215–1218. 17 indexed citations
12.
Kimura, Takemi, et al.. (1997). Apolipoprotein E ϵ2 allele and early onset schizophrenia. Neuroscience Letters. 231(1). 53–55. 19 indexed citations
13.
Kimura, Takemi, Shoichi Katsuragi, Tsunehiko Ono, et al.. (1996). Immunohistochemical examination of phosphorylated tau in granulovacuolar degeneration granules. Psychiatry and Clinical Neurosciences. 50(3). 137–140. 23 indexed citations
14.
Nakashima, Hisashi, et al.. (1996). Erythrocyte deformability in schizophrenic patients. Psychiatry and Clinical Neurosciences. 50(4). 191–194. 7 indexed citations
15.
Kimura, Takemi, Kazuyoshi Ikeda, Junichi Takamatsu, et al.. (1996). Identification of advanced glycation end products of the Maillard reaction in Pick's disease. Neuroscience Letters. 219(2). 95–98. 27 indexed citations
16.
Kimura, Takemi, Junichi Takamatsu, Norie Araki, et al.. (1995). Are advanced glycation end-products associated with amyloidosis in Alzheimer’s disease?. Neuroreport. 6(6). 866–868. 49 indexed citations
17.
Kimura, Takemi, et al.. (1994). Re-evaluation of classic senile plaques by three-dimensional analysis. Journal of Neurology. 241(10). 624–627. 4 indexed citations
18.
Kimura, Takemi, et al.. (1993). Classification of Senile Plaques by Three‐Dimensional Analysis. Psychiatry and Clinical Neurosciences. 47(3). 657–660. 3 indexed citations
19.
Miyakawa, Taihei, et al.. (1992). The distribution of α1-antichymotrypsin and amyloid production in the brain in Alzheimer’s disease. Virchows Archiv B Cell Pathology Including Molecular Pathology. 61(1). 331–335. 9 indexed citations
20.
Kimura, Takemi, et al.. (1991). Morphological Changes of Blood Vessels in the Brain with Alzheimer's Disease. Psychiatry and Clinical Neurosciences. 45(3). 661–665. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026